Endpoints News7d
No­vo Nordisk looks in­to start­ing GLP-1 drug tri­als for ad­dic­tion
Novo Nordisk considers exploring GLP-1 drugs like semaglutide for addiction treatment, following Eli Lilly's interest.
The Lancet8d
GLP-1 receptor agonists: even for kidney transplant recipients with pre-existing diabetes?
GLP-1 receptor agonists were initially approved for glycaemic control in type 2 diabetes and, subsequently, for bodyweight loss in obesity. Following large-scale trials demonstrating that some GLP-1 ...
The BMJ15d
GLP-1 receptor agonists and suicidality
Evidence suggests no increased risk The use of glucagon-like peptide-1 (GLP-1) receptor agonists has surged in recent years, driven by their benefits in glucose control in type 2 diabetes, weight ...
Dallas Morning News29d
All-you-can’t-eat: GLP-1 drugs pose new challenges for restaurants, but how do they work?
This story has been updated to include a link to a related podcast from The Dallas Morning News on the topic of GLP-1s. When Trova Wine and Market shut its doors last month after nearly five years ...
Yahoo9d
More yogurt and nuts, less alcohol and snack foods: How GLP-1 medications like Ozempic are influencing people’s food spending habits
Research shows that people on GLP-1 medications are ditching processed foods and buying more nutrient-dense ones like fresh produce, beans and yogurt. (Photo illustrations: Yahoo News; photos ...
Yahoo Finance17d
resbiotic Unveils resM™ GLP-1 Postbiotic--A Groundbreaking Innovation in Gut & Metabolic Health
Feb. 25, 2025 /PRNewswire/ -- resbiotic (res), a leading physician-developed supplement brand, announced today the launch of their latest product innovation, resM™ GLP-1 Postbiotic. resM™ is a ...